1649. Ceftolozane-Tazobactam or Ceftazidime-Avibactam Versus Best Available Therapy in the Treatment of Difficult-to-Treat Pseudomonas aeruginosa Infections: a Retrospective Comparative Effectiveness Analysis of 195 U.S. Hospitals, 2016–2020

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2022-12, Vol.9 (Supplement_2)
Main Authors: Lawandi, Alexander, Mishuk, Ahmed Ullah, Yek, Christina, Yu, Amy, Li, Xiaobai, Strich, Jeffrey R, Sarzynski, Sadia, Warner, Sarah, Kadri, Sameer S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofac492.115